Osteoporosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a neurological disorder (a condition affecting the brain, spinal cord, or nerves)
- Healthy people with no medical conditions who can take part as a comparison group (controls)
Who may not be able to join:
- People who are unable to fully understand and agree to participate in the study due to a legal or mental incapacity
- People who have, or have had, certain conditions affecting bone health, such as underactive parathyroid glands, overactive parathyroid glands, an overactive thyroid in the last six months, or Paget's disease of bone
- People who currently have severe pressure sores (open wounds on the skin, graded 3 or 4 in severity)
- People who have taken certain medications that affect bone density before the study's first bone scan, including bone-strengthening drugs called bisphosphonates in the past year, parathyroid hormone treatment in the past year, or hormone-related treatments (such as estrogens, SERMs, tibolone, or anabolic steroids) in the past six months
- People taking thyroid medication where the dose has changed in the last six weeks, or whose thyroid hormone levels are not in the normal range (confirm with trial site)
- People who have taken steroid medications (such as prednisone) at a dose above 7.5 mg per day for more than one month within the past six months
- People who have received immune-suppressing treatments within the past year
- People taking high doses of Vitamin A (above 10,000 IU per day) or high doses of Vitamin D (above 5,000 IU per day)
- People who plan to take extra Vitamin D supplements of more than 400 IU per day, or travel to areas with significantly more sunshine than usual, during the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yannis Dionyssiotis, National Rehabilitation Center EKA
Phone: 00306946469759
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants with neurological disease and low levels of vitamin D
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.